Niagen Bioscience (NAGE) Gross Margin Growth (3y) (2014 - 2026)

Niagen Bioscience (NAGE) Gross Margin Growth (3y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -230.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -168.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 193,280.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 589.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 6.06 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 53.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 569.00
10 Niagen Bioscience 238.30 Mn 171.56 Mn 19.31 Mn 405.00

Historic Data

Download Data
DateValue
Jun 30, 2026 405.00
Mar 31, 2026 354.00
Dec 31, 2025 691.00
Sep 30, 2025 470.00
Jun 30, 2025 498.00
Mar 31, 2025 240.00
Dec 31, 2024 128.00
Sep 30, 2024 237.00
Jun 30, 2024 -86.00
Mar 31, 2024 -215.00
Dec 31, 2023 4.00
Sep 30, 2023 178.00
Jun 30, 2023 135.00
Mar 31, 2023 199.00
Dec 31, 2022 20.00
Sep 30, 2022 383.00
Jun 30, 2022 368.00
Mar 31, 2022 827.00
Dec 31, 2021 924.00
Sep 30, 2021 741.00